» Articles » PMID: 11230154

Continuous Expression of Cbfa1 in Nonhypertrophic Chondrocytes Uncovers Its Ability to Induce Hypertrophic Chondrocyte Differentiation and Partially Rescues Cbfa1-deficient Mice

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2001 Mar 7
PMID 11230154
Citations 197
Authors
Affiliations
Soon will be listed here.
Abstract

Chondrocyte hypertrophy is a mandatory step during endochondral ossification. Cbfa1-deficient mice lack hypertrophic chondrocytes in some skeletal elements, indicating that Cbfa1 may control hypertrophic chondrocyte differentiation. To address this question we generated transgenic mice expressing Cbfa1 in nonhypertrophic chondrocytes (alpha1(II) Cbfa1). This continuous expression of Cbfa1 in nonhypertrophic chondrocytes induced chondrocyte hypertrophy and endochondral ossification in locations where it normally never occurs. To determine if this was caused by transdifferentiation of chondrocytes into osteoblasts or by a specific hypertrophic chondrocyte differentiation ability of Cbfa1, we used the alpha1(II) Cbfa1 transgene to restore Cbfa1 expression in mesenchymal condensations of the Cbfa1-deficient mice. The transgene restored chondrocyte hypertrophy and vascular invasion in the bones of the mutant mice but did not induce osteoblast differentiation. This rescue occurred cell-autonomously, as skeletal elements not expressing the transgene were not affected. Despite the absence of osteoblasts in the rescued animals there were multinucleated, TRAP-positive cells resorbing the hypertrophic cartilage matrix. These results identify Cbfa1 as a hypertrophic chondrocyte differentiation factor and provide a genetic argument for a common regulation of osteoblast and chondrocyte differentiation mediated by Cbfa1.

Citing Articles

Development of novel osteoarthritis therapy by targeting AMPK-β-catenin-Runx2 signaling.

Zeng D, Umar M, Zhu Z, Pan H, Lu W, Xiao G Genes Dis. 2024; 12(1):101247.

PMID: 39552787 PMC: 11566674. DOI: 10.1016/j.gendis.2024.101247.


Regulation of Skeletal Development and Maintenance by Runx2 and Sp7.

Komori T Int J Mol Sci. 2024; 25(18).

PMID: 39337587 PMC: 11432631. DOI: 10.3390/ijms251810102.


MiR-539-3p Alleviates Apoptosis and Extracellular Matrix Degradation in Chondrocytes of Childhood-Onset Osteoarthritis by Targeting RUNX2.

Jin T, Zheng H, Feng X, Wu T, Yang K, Huang Y Physiol Res. 2024; 73(3):415-426.

PMID: 39027958 PMC: 11299779. DOI: 10.33549/physiolres.935291.


Runx2 and Polycystins in Bone Mechanotransduction: Challenges for Therapeutic Opportunities.

Gargalionis A, Adamopoulos C, Vottis C, Papavassiliou A, Basdra E Int J Mol Sci. 2024; 25(10).

PMID: 38791330 PMC: 11121608. DOI: 10.3390/ijms25105291.


Runx2 Regulates and Expressions and Galnt3 Decelerates Osteoid Mineralization by Stabilizing Fgf23.

Jiang Q, Qin X, Moriishi T, Fukuyama R, Katsumata S, Matsuzaki H Int J Mol Sci. 2024; 25(4).

PMID: 38396954 PMC: 10889289. DOI: 10.3390/ijms25042275.


References
1.
Bi W, Deng J, Zhang Z, Behringer R, de Crombrugghe B . Sox9 is required for cartilage formation. Nat Genet. 1999; 22(1):85-9. DOI: 10.1038/8792. View

2.
Erlebacher A, Filvaroff E, Gitelman S, Derynck R . Toward a molecular understanding of skeletal development. Cell. 1995; 80(3):371-8. DOI: 10.1016/0092-8674(95)90487-5. View

3.
Inada M, Yasui T, Nomura S, Miyake S, Deguchi K, Himeno M . Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn. 1999; 214(4):279-90. DOI: 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W. View

4.
Jeske Y, Mishina Y, Cohen D, Behringer R, Koopman P . Analysis of the role of Amh and Fra1 in the Sry regulatory pathway. Mol Reprod Dev. 1996; 44(2):153-8. DOI: 10.1002/(SICI)1098-2795(199606)44:2<153::AID-MRD3>3.0.CO;2-M. View

5.
Bronckers A, Goei W, Luo G, Karsenty G, DSouza R, Lyaruu D . DNA fragmentation during bone formation in neonatal rodents assessed by transferase-mediated end labeling. J Bone Miner Res. 1996; 11(9):1281-91. DOI: 10.1002/jbmr.5650110913. View